101 related articles for article (PubMed ID: 15650051)
1. Directing oncogenic fusion genes into stem cells via an SCL enhancer.
Eguchi M; Eguchi-Ishimae M; Green A; Enver T; Greaves M
Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1133-8. PubMed ID: 15650051
[TBL] [Abstract][Full Text] [Related]
2. Developmental impact of leukemic fusion genes on stem cell fate.
Enver T; Tsuzuki S; Brown J; Hong D; Gupta R; Ford T; Egucchi MI; Egucchi M; Greaves M
Ann N Y Acad Sci; 2005 Jun; 1044():16-23. PubMed ID: 15958693
[TBL] [Abstract][Full Text] [Related]
3. Modeling first-hit functions of the t(12;21) TEL-AML1 translocation in mice.
Tsuzuki S; Seto M; Greaves M; Enver T
Proc Natl Acad Sci U S A; 2004 Jun; 101(22):8443-8. PubMed ID: 15155899
[TBL] [Abstract][Full Text] [Related]
4. Mesodermal patterning activity of SCL.
Ismailoglu I; Yeamans G; Daley GQ; Perlingeiro RC; Kyba M
Exp Hematol; 2008 Dec; 36(12):1593-603. PubMed ID: 18809240
[TBL] [Abstract][Full Text] [Related]
5. Defining the oncogenic function of the TEL/AML1 (ETV6/RUNX1) fusion protein in a mouse model.
Fischer M; Schwieger M; Horn S; Niebuhr B; Ford A; Roscher S; Bergholz U; Greaves M; Löhler J; Stocking C
Oncogene; 2005 Nov; 24(51):7579-91. PubMed ID: 16044150
[TBL] [Abstract][Full Text] [Related]
6. Tel/PDGFRbeta induces stem cell differentiation via the Ras/ERK and STAT5 signaling pathways.
Dobbin E; Graham C; Corrigan PM; Thomas KG; Freeburn RW; Wheadon H
Exp Hematol; 2009 Jan; 37(1):111-121. PubMed ID: 19100521
[TBL] [Abstract][Full Text] [Related]
7. MN1-TEL, the product of the t(12;22) in human myeloid leukemia, immortalizes murine myeloid cells and causes myeloid malignancy in mice.
Carella C; Bonten J; Rehg J; Grosveld GC
Leukemia; 2006 Sep; 20(9):1582-92. PubMed ID: 16810199
[TBL] [Abstract][Full Text] [Related]
8. Transgenic analysis of the stem cell leukemia +19 stem cell enhancer in adult and embryonic hematopoietic and endothelial cells.
Silberstein L; Sánchez MJ; Socolovsky M; Liu Y; Hoffman G; Kinston S; Piltz S; Bowen M; Gambardella L; Green AR; Göttgens B
Stem Cells; 2005 Oct; 23(9):1378-88. PubMed ID: 16051983
[TBL] [Abstract][Full Text] [Related]
9. TEL-AML1, expressed from t(12;21) in human acute lymphocytic leukemia, induces acute leukemia in mice.
Bernardin F; Yang Y; Cleaves R; Zahurak M; Cheng L; Civin CI; Friedman AD
Cancer Res; 2002 Jul; 62(14):3904-8. PubMed ID: 12124316
[TBL] [Abstract][Full Text] [Related]
10. Organ-injury-induced reactivation of hemangioblastic precursor cells.
Dekel B; Metsuyanim S; Garcia AM; Quintero C; Sanchez MJ; Izraeli S
Leukemia; 2008 Jan; 22(1):103-13. PubMed ID: 17898790
[TBL] [Abstract][Full Text] [Related]
11. Differential Hox expression in murine embryonic stem cell models of normal and malignant hematopoiesis.
Wheadon H; Ramsey JM; Dobbin E; Dickson GJ; Corrigan PM; Freeburn RW; Thompson A
Stem Cells Dev; 2011 Aug; 20(8):1465-76. PubMed ID: 21083428
[TBL] [Abstract][Full Text] [Related]
12. TEL-AML1 promotes development of specific hematopoietic lineages consistent with preleukemic activity.
Morrow M; Horton S; Kioussis D; Brady HJ; Williams O
Blood; 2004 May; 103(10):3890-6. PubMed ID: 14726384
[TBL] [Abstract][Full Text] [Related]
13. Tel/PDGFRbeta inhibits self-renewal and directs myelomonocytic differentiation of ES cells.
Dobbin E; Corrigan PM; Walsh CP; Welham MJ; Freeburn RW; Wheadon H
Leuk Res; 2008 Oct; 32(10):1554-64. PubMed ID: 18355917
[TBL] [Abstract][Full Text] [Related]
14. Targeting PIM kinases impairs survival of hematopoietic cells transformed by kinase inhibitor-sensitive and kinase inhibitor-resistant forms of Fms-like tyrosine kinase 3 and BCR/ABL.
Adam M; Pogacic V; Bendit M; Chappuis R; Nawijn MC; Duyster J; Fox CJ; Thompson CB; Cools J; Schwaller J
Cancer Res; 2006 Apr; 66(7):3828-35. PubMed ID: 16585210
[TBL] [Abstract][Full Text] [Related]
15. Enforced activation of STAT5A facilitates the generation of embryonic stem-derived hematopoietic stem cells that contribute to hematopoiesis in vivo.
Schuringa JJ; Wu K; Morrone G; Moore MA
Stem Cells; 2004; 22(7):1191-204. PubMed ID: 15579639
[TBL] [Abstract][Full Text] [Related]
16. The RAC specific guanine nucleotide exchange factor Asef functions downstream from TEL-AML1 to promote leukaemic transformation.
Lyons R; Williams O; Morrow M; Sebire N; Hubank M; Anderson J
Leuk Res; 2010 Jan; 34(1):109-15. PubMed ID: 19628279
[TBL] [Abstract][Full Text] [Related]
17. The detection of Tel-TrkC chimeric transcripts is more specific than TrkC immunoreactivity for the diagnosis of congenital fibrosarcoma.
Dubus P; Coindre JM; Groppi A; Jouan H; Ferrer J; Cohen C; Rivel J; Copin MC; Leroy JP; de Muret A; Merlio JP
J Pathol; 2001 Jan; 193(1):88-94. PubMed ID: 11169520
[TBL] [Abstract][Full Text] [Related]
18. Zebrafish scl functions independently in hematopoietic and endothelial development.
Dooley KA; Davidson AJ; Zon LI
Dev Biol; 2005 Jan; 277(2):522-36. PubMed ID: 15617691
[TBL] [Abstract][Full Text] [Related]
19. TEL-JAK2 transgenic mice develop T-cell leukemia.
Carron C; Cormier F; Janin A; Lacronique V; Giovannini M; Daniel MT; Bernard O; Ghysdael J
Blood; 2000 Jun; 95(12):3891-9. PubMed ID: 10845925
[TBL] [Abstract][Full Text] [Related]
20. Constitutively active STAT5 variants induce growth and survival of hematopoietic cells through a PI 3-kinase/Akt dependent pathway.
Santos SC; Lacronique V; Bouchaert I; Monni R; Bernard O; Gisselbrecht S; Gouilleux F
Oncogene; 2001 Apr; 20(17):2080-90. PubMed ID: 11360192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]